In a Turkish series, 3/16 CGL1 patients had CAD at age 30, 62, and 62, respectively, carrying c.662–2A > C (IVS5–2A > C), c.202C > T (p.R68*), and c.685G > T (p.E229*) AGPAT2 mutations. Here, AGPAT2 is linked to coronary artery disorder.